Altaire Pharmaceuticals Issues Voluntary Recall of Multiple Ophthalmic Products

July 8, 2019

Altaire Pharmaceuticals has voluntarily recalled several ophthalmic drugs due to management concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility. This recall is being carried out to the retail level and is only for the specific lots listed.

The recalled drugs include:


Read the full press release